Videos de Experimentos Relacionados
La pentamidina nebulizada también se usa.
Lancet (London, England)
|March 19, 1988
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Smoking and HIV associated with subclinical tuberculosis: analysis of a population-based prevalence survey.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2020
Same author
Secondary analysis of tuberculosis stigma data from a cluster randomised trial in Zambia and South Africa (ZAMSTAR).
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2017
Same author
Coverage of clinic-based TB screening in South Africa may be low in key risk groups.
Public health action·2016
Same author
Health care workers' gender bias in testing could contribute to missed tuberculosis among women in South Africa.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2016
Same author
Symptom reporting among prevalent tuberculosis cases who smoke, are HIV-positive or have hyperglycaemia.
Public health action·2015
Same author
Decentralised care for the management of child contacts of multidrug-resistant tuberculosis.
Public health action·2015
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026